Table 4—

Mean Asthma Quality of Life Questionnaire(AQLQ) scores at 52 weeks and mean change from baseline within each strata split by level of asthma control at the end of phase II

Stratum 1Stratum 2Stratum 3Overall
SFCFPSFCFPSFCFPSFCFP
TC
 Patients n7757110506637253144
 Score at 52 weeks6.5±0.786.6±0.476.6±0.556.5±0.646.6±0.546.5±0.476.5±0.636.6±0.53
 Mean change2.0±1.092.1±1.081.8±1.071.7±1.211.9±0.841.7±1.031.9±1.021.8±1.12
WC
 Patients n7367101889690270245
 Score at 52 weeks6.2±0.676.2±0.776.1±0.806.1±0.746.2±0.786.1±0.866.2±0.766.1±0.79
 Mean change1.8±1.171.6±0.901.4±0.921.5±1.121.5±1.101.3±0.841.5±1.061.5±0.97
NWC
 Patients n689290142129150287384
 Score at 52 weeks5.4±1.125.5±1.055.4±1.205.4±1.185.2±1.195.1±1.095.3±1.185.3±1.12
 Mean change1.2±1.251.1±1.130.9±1.080.9±1.090.9±1.020.8±1.041.0±1.100.9±1.09
  • Data are presented as mean±sd, unless otherwise stated. SFC: salmeterol/fluticasone propionate combination; FP: fluticasone propionate; TC: total control; WC: well-controlled; NWC: not well-controlled.